The FDA has cleared RELiZORB (immobilized lipase) cartridge for use in pediatric patients aged 2 to less than 5 years old experiencing fat malabsorption.
Some 1,200 cancer survivors gathered for Northwell Health's annual Don Monti Cancer Survivors Day celebration at the R.J. Zuckerberg Cancer Center in Lake Success.
/PRNewswire/ Alcresta Therapeutics, Inc., a leading commercial-stage company focused on developing and commercializing novel enzyme-based products, today.